The programme integrates simulation-based training, expert-led sessions, and case-based discussions
The company announced that its Phase III FENhance 1 and 2 studies both met their primary endpoints
The start of our Phase 3 trial for an H5 influenza vaccine marks a significant milestone
IgAN is a rare, progressive kidney disease driven by abnormal IgA immune complexes that deposit in the kidneys
The conclave brought together key stakeholders from across the assisted living ecosystem
The newly formed SAB will provide strategic direction across research, clinical development, and regulatory pathways
The new facility is expected to significantly improve access to high-quality medical services for patients across Gujarat and neighbouring regions
The programme has already drawn over 120 complex percutaneous coronary intervention (PCI) case submissions from across the country
Spread across 7,000 square feet, the Bengaluru facility is positioned as a purpose-built clinical prevention centre focused on identifying silent, life-threatening diseases in asymptomatic individuals
AI-enabled learning platform to enhance clinical quality, patient outcomes, and staff engagement across Eastern India network
Subscribe To Our Newsletter & Stay Updated
